Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models

BACKGROUND: Toll-like receptor (TLR)3 ligands serve as natural inducers of pro-inflammatory cytokines capable of promoting Type-1 adaptive immunity, and TLR3 is abundantly expressed by cells within the central nervous system (CNS). To improve the efficacy of vaccine strategies directed against CNS t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xinmei, Nishimura, Fumihiko, Sasaki, Kotaro, Fujita, Mitsugu, Dusak, Jill E, Eguchi, Junichi, Fellows-Mayle, Wendy, Storkus, Walter J, Walker, Paul R, Salazar, Andres M, Okada, Hideho
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802742/
https://www.ncbi.nlm.nih.gov/pubmed/17295916
http://dx.doi.org/10.1186/1479-5876-5-10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1802742/
https://www.ncbi.nlm.nih.gov/pubmed/17295916
http://dx.doi.org/10.1186/1479-5876-5-10

Ejemplares similares